Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CCCC
#2959
C4 Therapeutics, Inc.
2.7
0
-1.46%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-1.46%
Mudança mensal
+26.17%
Mudança em 6 meses
+5.06%
Mudança anual
+4.25%
Fechamento anterior
2.7
4
Open
2.7
0
Bid
Ask
Low
2.7
0
High
2.7
0
Volume
57
Mercados
Ações
Cuidados de saúde
CCCC
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
43.12 M
48.74 M
49.05 M
68.6 M
70.99 M
97.58 M
—
Valuation ratios
Enterprise value
1.25 B
1.49 B
283.19 M
320.69 M
200.06 M
111.77 M
354.05 M
Price to earnings ratio
—
—
-2.44
-2.44
-2.37
-1.5
-4.81
Price to sales ratio
—
—
10.03
15.59
7.02
—
—
Price to cash flow ratio
—
—
2.94
3.03
3.83
1.6
5.82
Price to book ratio
—
—
1.08
1.32
1.16
0.62
1.07
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.17
0.17
0.3
0.35
0.3
0.29
0.35
Return on equity %
0.24
0.22
0.44
0.54
0.49
0.41
0.57
Return on invested capital %
460.27
313.53
258.91
346.35
357.39
364.29
418.25
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
416.56
669.84
336.15
320.53
1 360.45
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
412.19
638.34
295.96
292.08
1 238.66
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.69
6.36
6.46
6.34
5.71
7.81
24.32
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0.07
0.05
0.1
0.1
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.03
0.02
0.02
0
—
—
—
Long term debt to total equity ratio
0.04
0.03
0.03
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.17
2.15
0.94
1.19
1.34
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
6.9
5.67
3.85
3.58
12.79
Net current asset value per share
—
—
5.89
5.46
3.72
3.11
12.41
Tangible book value per share
—
—
5.92
4.96
3.11
3.1
10.43
Working capital per share
—
—
4.97
4.6
3.06
2.72
10.32
Book value per share
—
—
5.92
4.96
3.11
3.1
10.43
Notícias
Barclays eleva preço-alvo das ações da C4 Therapeutics após avanço em ensaios
Barclays raises C4 Therapeutics stock price target on trial progress
TD Cowen reitera classificação de Compra para ações da C4 Therapeutics
TD Cowen reiterates Buy rating on C4 Therapeutics stock
Lucro da C4 superou projeções por $0,11; receita supera estimativas
C4 earnings beat by $0.11, revenue topped estimates
Brookline Capital eleva preço-alvo da C4 Therapeutics com avanço em ensaios
Brookline Capital raises C4 Therapeutics stock price target on trial progress
C4 Therapeutics doses first patient in phase 2 myeloma trial
Diretor médico da C4 Therapeutics vende ações no valor de US$ 22.200
C4 Therapeutics’ chief medical officer Reyno sells $22,200 in stock
C4 Therapeutics avançará testes de cemsidomide para mieloma múltiplo